SFE Investment Counsel’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $289K | Buy |
2,284
+13
| +0.6% | +$1.65K | 0.05% | 123 |
|
|
2025
Q1 | $291K | Sell |
2,271
-90
| -4% | -$11.5K | 0.06% | 118 |
|
|
2024
Q4 | $312K | Sell |
2,361
-239
| -9% | -$31.6K | 0.07% | 97 |
|
|
2024
Q3 | $379K | Sell |
2,600
-169
| -6% | -$24.6K | 0.08% | 101 |
|
|
2024
Q2 | $380K | Buy |
2,769
+88
| +3% | +$12.1K | 0.08% | 100 |
|
|
2024
Q1 | $368K | Buy |
2,681
+23
| +0.9% | +$3.16K | 0.08% | 109 |
|
|
2023
Q4 | $361K | Sell |
2,658
-145
| -5% | -$19.7K | 0.09% | 100 |
|
|
2023
Q3 | $343K | Sell |
2,803
-744
| -21% | -$91K | 0.1% | 104 |
|
|
2023
Q2 | $450K | Buy |
3,547
+4
| +0.1% | +$508 | 0.13% | 97 |
|
|
2023
Q1 | $460K | Sell |
3,543
-69
| -2% | -$8.96K | 0.14% | 92 |
|
|
2022
Q4 | $484K | Sell |
3,612
-484
| -12% | -$64.9K | 0.15% | 92 |
|
|
2022
Q3 | $479K | Buy |
4,096
+219
| +6% | +$25.6K | 0.15% | 92 |
|
|
2022
Q2 | $456K | Sell |
3,877
-1
| -0% | -$118 | 0.14% | 94 |
|
|
2022
Q1 | $505K | Buy |
+3,878
| New | +$505K | 0.13% | 96 |
|